Skip to main content
Clinical Trials/CTRI/2021/04/032803
CTRI/2021/04/032803
Not yet recruiting
Phase 2

A Randomized Comparative Clinical Study On The Efficacy Of Mehmudgar Ras Vati With And Without Virechan Karma In The Management Of Timir W.S.R.To Diabetic Macular Edema (DME)

Dr Ankur Tripathi0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E083- Diabetes mellitus due to underlying condition with ophthalmic complications
Sponsor
Dr Ankur Tripathi
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ankur Tripathi

Eligibility Criteria

Inclusion Criteria

  • Patients willing to participate in this trial through written informed consent.
  • Patients who are 40\-70 years of age from either sex.
  • Patients having specific symptoms of prameh janya timira /D.M.E.
  • Diagnosed cases of diabetics mellitus type2 with NPDR cases with macular edema.
  • Good visual acuity, minimum 6/60 or better

Exclusion Criteria

  • Patients not willing for the present treatment.
  • Patients having history of glaucoma and on anti glaucoma treatment.
  • Patients below age of 40 and above 70\.
  • Patients with moderate to severe cataractous changes.
  • Patients having proliferative and advanced diabetic retinopathy changes.
  • Patients with any other complications of Diabetes like nephropathy and neuropathy.
  • Visual acuity less than 6/60\.
  • Hypertensive/pregnant/diabetic mellitus type 1

Outcomes

Primary Outcomes

Not specified

Similar Trials